N-Acetylated Monosaccharides and Derived Glycan Structures Occurring in N- and O-Glycans During Prostate Cancer...

Area of Science:

• Biochemistry
• Oncology
• Glycoscience

Background:

• Post-translational protein modifications are crucial for protein function.
• Glycosylation, a common modification, offers high cancer specificity, particularly in prostate cancer.
• Prostate cancer diagnostics can be enhanced by combining glycosylation insights with tissue-specific biomarkers like PSA, PSMA, and PAP.

Purpose of the Study:

• To review the significance of subterminal glycan structures, focusing on N-acetylated monosaccharides (GlcNAc, GalNAc).
• To discuss the role of these structures in N- and O-glycans, including LacNAc, LacdiNAc, and branched forms.
• To evaluate the clinical performance of these glycans in prostate cancer diagnostics via lectin-based methods.

Main Methods:

• Literature review focusing on subterminal glycan structures and their role in cancer.
• Analysis of N-acetylated monosaccharides (GlcNAc, GalNAc) within N- and O-glycans.
• Discussion of lectin-based affinity methods for detecting these glycan structures.

Main Results:

• Subterminal glycan structures involving GlcNAc and GalNAc are important components of N- and O-glycans.
• These structures, such as LacNAc and LacdiNAc, are relevant for cancer specificity.
• Lectin-based methods show potential for detecting these glycans in prostate cancer diagnostics.

Conclusions:

• Subterminal glycan structures, particularly those with N-acetylated monosaccharides, are significant for prostate cancer oncodiagnostics.
• The combination of specific glycan structures and established biomarkers may improve diagnostic accuracy.
• Lectin-based affinity methods offer a promising avenue for future clinical laboratory implementation in prostate cancer detection.